[Treatment of migraine].
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000700:Analgesics / Q000008:administration & dosage; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage; D002936:Cinnarizine / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004878:Ergotamine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007705:Kinins / Q000037:antagonists & inhibitors; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy* / Q000209:etiology; D012702:Serotonin Antagonists / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000929:Antidepressive Agents, Tricyclic; D007705:Kinins; D012702:Serotonin Antagonists; D002936:Cinnarizine; D003000:Clonidine; D004878:Ergotamine
Lechenie migreni.